In noncardioembolic ischemic stroke or high-risk TIA, asundexian reduced ischemic stroke and did not increase major bleeding
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Neurology: [Formula: see text] Hematology: [Formula: see text].
Authors
- Michael D. Hill (ORCID: https://orcid.org/0000-0002-6269-1543)
Institutions
- University of Calgary (CA)
Publication Details
- Journal
- Annals of Internal Medicine
- Published
- 2026-08-03
- DOI
- https://doi.org/10.7326/annals-26-02578-jc
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00